Have a personal or library account? Click to login
Pulmonary and Cerebral Infarcts Due to Secondary Thrombosis Risk of a Genetic Mutation: Life-threating Methylentetrahydrofolate Reductase (MTHFR) Deficiency with Early Onset Cover

Pulmonary and Cerebral Infarcts Due to Secondary Thrombosis Risk of a Genetic Mutation: Life-threating Methylentetrahydrofolate Reductase (MTHFR) Deficiency with Early Onset

Open Access
|May 2016

References

  1. 1. Forges T, Chery C, Audonnet S, et al. Life-threatening methylenetetrahydrofolate reductase (MTHFR) deficiency with extremely early onset: Characterization of two novel mutations in compound heterozygous patients. Molecular Genetics and Metabolism 2010;100:143–148;10.1016/j.ymgme.2010.03.002
  2. 2. K. Kchock, A. Omezzine, L. Rebhi, et al. Preanalytical conditions for the measurement of plasma total homocysteine: genotype C677T MTHFR dependent non-fasting variations and anticoagulant effects on stability. Immuno-analyse et biologie spécialisée 2007;22 :319–324;10.1016/j.immbio.2007.06.005
  3. 3. Nazki FH, Sameer AS, Ganaie BA. Folate: Metabolism, genes, polymorphisms and the associated diseases. Gene. 2014;533:11–20;10.1016/j.gene.2013.09.063
  4. 4. Simsek E, Yesilyurt A, Pinarli F, Eyerci N, Ulus AT. Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence: Gene. 2014;536:171–176;10.1016/j.gene.2013.11.019
  5. 5. Joachim E, Goldenberg NA, Bernard TJ, et al. The Methylentetrahydrofolate Reductase Polymorphism (MTHFR c.677C > T) and Elevated Plasma Homocysteine Levels in a U.S. Pediatric Population with Incident Thromboembolism. Thromb Res. 2013;132:170–174;10.1016/j.thromres.2013.06.005
  6. 6. Del Balzo F, Spalice A, Perla M, Properzi E, Iannetti P. MTHFR homozygous mutation and additional risk factors for cerebral infarction in a large italian family. Pediatr Neurol. 2009;40:63-67;10.1016/j.pediatrneurol.2008.09.023
  7. 7. Cha SI1, Shin KM, Lee J, et al. Clinical relevance of pulmonary infarction in patients with pulmonary embolism. Thromb Res. 2012;130:e1–e5;10.1016/j.thromres.2012.03.012
  8. 8. Li P, Qin C. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and susceptibility to ischemic stroke: A meta-analysis. Gene. 2014;535:359–364;10.1016/j.gene.2013.09.066
  9. 9. Sazci A, Ergul E, Tuncer N, Akpinar G, Kara I. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C. Brain Res Bull. 2006;71:45–50;10.1016/j.brainresbull.2006.07.014
  10. 10. Gouveia LO, Canhão P. MTHFR and the risk for cerebral venous thrombosis- a meta-analysis. Thromb Res. 2010;125:e153–e158;10.1016/j.thromres.2009.10.019
DOI: https://doi.org/10.1515/amma-2016-0026 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 269 - 271
Submitted on: Dec 28, 2015
Accepted on: Mar 20, 2016
Published on: May 20, 2016
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Edith Simona Ianosi, Szasz Simona, Roxana Nemes, Gabriela Jimborean, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.